Stress Hyperglycemia and Acute Ischemic Stroke
- Conditions
- Stress Hyperglycemia
- Interventions
- Other: standard protocol for stroke patients
- Registration Number
- NCT04408768
- Lead Sponsor
- Ain Shams University
- Brief Summary
Whereas diabetes mellitus is clearly a risk factor for the occurrence of stroke and for its poor prognosis, hyperglycemia per se is also linked to increased morbidity and mortality in stroke patients.Therefore, the objective of this work was to study the glycemic status of acute ischemic stroke patients and to assess its impact on stroke outcome.
- Detailed Description
Using PASS program, setting alpha error at 5% and power of 80%, the total sample size was estimated to be 80 cases.
The NIHSS was used as a primary outcome; 40 cases were needed in each group. Secondary outcomes were hemorrhagic transformation, hospital stay duration, mechanical ventilation, need for vasopressors, and 30-days mortality.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- Acute ischemic stroke within 24 hours of onset of symptoms
- subdural hematoma
- Transient ischemic attack
- Subarachnoid hemorrhage
- Hemorrhagic stroke
- Major comorbidities Hyperglycemia on admission that was controlled (random blood sugar (RBS) < 150 mg/dl) within 24 hours with insulin therapy, diabetic
- Ketoacidosis
- RBS less than 70 mg/dl on admission
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description High RBS standard protocol for stroke patients High RBS on ICU admission and uncontrolled blood sugar during first 24 hours Normal RBS standard protocol for stroke patients Normal RBS on ICU admission and controlled blood sugar within 24 hours
- Primary Outcome Measures
Name Time Method National Institutes of Health Stroke Scale (NIHSS) 30 days The NIHSS score categorized into: no stroke symptoms (0), mild stroke (1-4), moderate stroke (5-15), moderate to severe stroke (16-20), and sever (21-42)
- Secondary Outcome Measures
Name Time Method 30-days mortality 30 days Hemorrhagic transformation, the length of hospital stay, need for mechanical ventilation and vasopressors and 30-days mortality
Trial Locations
- Locations (1)
Hanaa El Gendy
🇪🇬Cairo, Ain Shams University Specialized Hospital, Egypt